Blood Plasma Derivatives Global Market Generated Opportunities, Future Scope 2024-2033 | Bayer AG, Sanofi S.A., CSL Limited, Meiji Group, Grifols S.A.

The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2033

The Business Research Company offers in-depth market insights through Blood Plasma Derivatives Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.

Market Size And Growth Forecast:
The blood plasma derivatives market size has grown strongly in recent years. It will grow from $48.26 billion in 2023 to $52.61 billion in 2024 at a compound annual growth rate (CAGR) of 9.0%. The growth in the historic period can be attributed to increased prevalence of hemophilia and bleeding disorders, growth in geriatric population, increased awareness and diagnosis, rise in surgical procedures, global blood transfusion services.

The blood plasma derivatives market size is expected to see strong growth in the next few years. It will grow to $75 billion in 2028 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to emergence of rare diseases therapies, growth in chronic diseases, increasing healthcare expenditure, patient-centric treatment approaches, growing healthcare infrastructure. Major trends in the forecast period include advancements in fractionation technologies, patient-centric approaches, collaborations and partnerships, expanding applications in neurology, technological innovations in plasma fractionation.

Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=12107&type=smp

Market Segmentation:
The blood plasma derivatives market covered in this report is segmented -
1) By Type: Albumin, Factor VIII, Factor IX, Immunoglobulin, Hyperimmune Globulin, Other Types
2) By Application: Hemophilia, Hypogammaglobulinemia, Immunodeficiency Diseases, Von Willebrand's Disease, Other Applications
3) By End-User: Hospitals, Clinics, Other End-Users

Major Driver - Surging Demand For Blood Plasma Derivatives Driven By The Increasing Prevalence Of Immune Deficiency Disorders
The increasing prevalence of immunodeficiency disorders is expected to drive the growth of the blood plasma derivatives market. Immunodeficiency disorders are illnesses that either completely or partially compromise the immune system. Blood plasma derivatives find application in treating a multitude of medical conditions, including immune deficiency disorders. Plasma, a solution consisting of proteins and salts, encompasses over 100 different proteins, among which immunoglobulins are particularly utilized for addressing primary immunodeficiencies. Poor nutrition or malnutrition leads to macro- and micronutrient deficiencies, which can lead to immunodeficiency. For instance, in July 2022, according to another report shared by WHO, globally, 828 million people were impacted by hunger in 2021. Hunger is a major contributor to malnutrition. Therefore, the increasing prevalence of immune deficiency disorders is driving the growth of the blood plasma derivatives market.

Competitive Landscape:
Major companies operating in the blood plasma derivatives market report are Bayer AG, Sanofi S.A., Takeda Pharmaceutical Company Limited, Baxter International Inc., CSL Limited, Meiji Group, Grifols S.A., Shire Pharmaceuticals Inc., GC Biopharma Corp, Emergent BioSolutions Inc., Shanghai Raas Blood Products Co Ltd., Kedrion S.p.A., Sanquin, Biotest AG, Bio Products Ltd., ADMA Biologics Inc., China Biologic Products Holdings Inc., BioIVT, PlasmaGen BioSciences Pvt. Ltd., Virchow Biotech Private Limited, LFB S.A., Monobind Inc., Intas Pharmaceuticals Ltd., Octapharma Plasma, Fusion Pharmaceuticals Inc.

Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/blood-plasma-derivatives-global-market-report

Top Trend - Strategic Partnerships In The Blood Plasma Derivatives Market For Enhancing Access And Supply For Immunoglobulins In France And Beyond
Major companies operating in the blood plasma derivatives market are focused on adopting strategic partnerships to gain a competitive edge in the market. With this partnership, patients in need will have access to a steady and dependable supply of these vital plasma-derived medications, helping to meet the increasing need for immunoglobulins in France and beyond. For instance, in January 2022, Kedrion S.p.A. an Italy-based biopharmaceutical company specializing in the development, production, and distribution of plasma-derived therapies partnered with LPB, a UK-based pharmaceutical company specializing in biological medicinal products. Kedrion will use LFB plasma obtained in France by the Etablissement Français du Sang (EFS) to produce immunoglobulins in Hungary. The current supply of immunoglobulins, which will be made available to hospitals across the nation in accordance with and under the supervision of French health authorities, will be supplemented by these imports from LFB in France.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Blood Plasma Derivatives Market Characteristics
3. Blood Plasma Derivatives Market Trends And Strategies
4. Blood Plasma Derivatives Market - Macro Economic Scenario
5. Blood Plasma Derivatives Market Size And Growth
…..
27. Blood Plasma Derivatives Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.

This release was published on openPR.